Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cockroach Immunotherapy in Children and Adolescents
NCT03541187Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2018
- Primary completion
- Jun 2022
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing G. cockroach allergenic extract with Placebo (2 arms). Primary endpoint: Change in Mean Total Nasal Symptom Score at 12 months. Started Jul 2018; status: completed.
02
Drugs
blattella germanica allergenic extract
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03541187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541187.